本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Trevi Therapeutics Inc.

14.95
-0.2600-1.71%
盤後14.950.00000.00%19:30 EDT
成交量:213.85萬
成交額:3,198.59萬
市值:21.23億
市盈率:-42.50
高:15.38
開:15.17
低:14.81
收:15.21
52周最高:20.22
52周最低:8.04
股本:1.42億
流通股本:1.18億
量比:1.13
換手率:1.81%
股息:- -
股息率:- -
每股收益(TTM):-0.3518
每股收益(LYR):-0.3173
淨資產收益率:-19.66%
總資產收益率:-13.82%
市淨率:6.60
市盈率(LYR):-47.11

資料載入中...

2023/04/11

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/16

重要事件披露

8-K - Current report
2023/03/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/10/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/23

重要事件披露

8-K - Current report
2022/09/19

重要事件披露

8-K - Current report
2022/08/11

重要事件披露

8-K - Current report
2022/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/29

重要事件披露

8-K - Current report
2022/06/23

重要事件披露

8-K - Current report